Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use

Journal of Hospital Infection

Volumn 50, Issue 1, 2002, Pages 56-65

  Hope, William ^a   Morton, A ^b   Eisen, D P ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Candida albicans; Candida krusei; Candidaemia; Fluconazole; RAPD

Indexed keywords

AMPICILLIN; FLUCONAZOLE; GENTAMICIN; IMIPENEM; METRONIDAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; FEMALE; FUNGEMIA; HOSPITAL INFECTION; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PREVALENCE; RANDOM AMPLIFIED POLYMORPHIC DNA; TOTAL PARENTERAL NUTRITION; CANDIDA; CANDIDIASIS; CROSS INFECTION; DRUG EFFECT; GENETICS; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; RISK FACTOR;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CROSS INFECTION; FLUCONAZOLE; FUNGEMIA; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS;

EID: 0036364176     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2001.1131     Document Type: Article

References (38)

1. Beck-Sague C Jarvis WR Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System J Infect Dis 167 1993 1247-1251
2. Jarvis WR Epidemiology of nosocomial fungal infections, with emphasis on Candida species Clin Infect Dis 20 1995 1526-1530
3. Anaissie EJ Rex JH Uzun O Vartivarian S Predictors of adverse outcome in cancer patients with candidemia Am J Med 104 1998 238-245
4. Viscoli C Girmenia C Marinus A Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC) Clin Infect Dis 28 1999 1071-1079
5. Wey SB Mori M Pfaller MA Woolson RF Wenzel RP Hospital-acquired candidemia. The attributable mortality and excess length of stay Arch Intern Med 148 1988 2642-2645
6. Komshian SV Uwaydah AK Sobel JD Crane LR Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome Rev Infect Dis 11 1989 379-390
7. Fridkin SK Jarvis WR Epidemiology of nosocomial fungal infections Clin Microbiol Rev 9 1996 499-511
8. Goodman JL Winston DJ Greenfield RA A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation N Engl J Med 326 1992 845-851
9. Slavin MA Osborne B Adams R Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study J Infect Dis 171 1995 1545-1552
10. Rotstein C Bow EJ Laverdiere M Ioannou S Carr D Moghaddam N Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian FluconazoleProphylaxis Study Group Clin Infect Dis 28 1999 331-340
11. Alangaden G Chandrasekar PH Bailey E Khaliq Y Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team Bone Marrow Transplant 14 1994 919-924
12. Winston DJ Chandrasekar PH Lazarus HM Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial Ann Intern Med 118 1993 495-503
13. Wey SB Mori M Pfaller MA Woolson RF Wenzel RP Risk factors for hospital-acquired candidemia. A matched case-control study Arch Intern Med 149 1989 2349-2353
14. Dean AD Dean JA Burton AH Dicker RC Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on micro-computers 1990 Stone Mountain Georgia
15. Kennett R Zacks S Modern Industrial Statistics 1998 Duxbury Press Pacific Grove
16. Siegel S Castellan J Nonparametric Statistics, 2nd edn. 1988 McGraw Hill New York
17. Steffan P Vazquez JA Boikov D Xu C Sobel JD Akins RA Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates J Clin Microbiol 35 1997 2031-2039
18. Berrouane YF Herwaldt LA Pfaller MA Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital J Clin Microbiol 37 1999 531-537
19. Stratov I Gottlieb T Bradbury R O'Kane GM Candidaemia in an Australian teaching hospital: relationship to central line and TPN use J Infect 36 1998 203-207
20. Abi-Said D Anaissie E Uzun O Raad I Pinzcowski H Vartivarian S The epidemiology of hematogenous candidiasis caused by different Candida species Clin Infect Dis 24 1997 1122-1128
21. Wingard JR Importance of Candida species other than C. albicans as pathogens in oncology patients Clin Infect Dis 20 1995 115-125
22. Wright WL Wenzel RP Nosocomial Candida. Epidemiology, transmission, and prevention Infect Dis Clin North Am 11 1997 411-425
23. Richet HM Andremont A Tancrede C Pico JL Jarvis WR Risk factors for candidemia in patients with acute lymphocytic leukemia Rev Infect Dis 13 1991 211-215
24. Wingard JR Merz WG Rinaldi MG Johnson TR Karp JE Saral R Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole N Engl J Med 325 1991 1274-1277
25. Nguyen MH Peacock JE Morris AJ The changing face of candidemia: emergence of non- Candida albicans species and antifungal resistance Am J Med 100 1996 617-623
26. Girmenia C Martino P De Bernardis F Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains Clin Infect Dis 23 1996 506-514
27. Girmenia C Martino P Cassone A Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies Blood 87 1996 838-839
28. Kunova A Trupl J Dluholucky S Galova G Krcmery V Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species Clin Infect Dis 21 1995 226-227
29. Merz WG Karp JE Schron D Saral R Increased incidence of fungemia caused by Candida krusei J Clin Microbiol 24 1986 581-584
30. White MH Editorial response: The contribution of fluconazole to the changing epidemiology of invasive Candidal infections Clin Infect Dis 24 1997 1129-1130
31. Isenberg HD Tucci V Cintron F Singer C Weinstein GS Tyras DH Single-source outbreak of Candida tropicalis complicating coronary bypass surgery J Clin Microbiol 27 1989 2426-2428
32. Burnie JP Odds FC Lee W Webster C Williams JD Outbreak of systemic Candida albicans in intensive care unit caused by cross infection Br Med J (Clin Res Ed) 290 1985 746-748
33. Weems JJ Chamberland ME Ward J Willy M Padhye AA Solomon SL Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers J Clin Microbiol 25 1987 1029-1032
34. Finkelstein R Reinhertz G Hashman N Merzbach D Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit Infect Control Hosp Epidemiol 14 1993 587-590
35. Moro ML Maffei C Manso E Morace G Polonelli L Biavasco F Nosocomial outbreak of systemic candidosis associated with parenteral nutrition Infect Control Hosp Epidemiol 11 1990 27-35
36. Sanchez V Vazquez JA Barth-Jones D Dembry L Sobel JD Zervos MJ Epidemiology of nosocomial acquisition of Candida lusitaniae J Clin Microbiol 30 1992 3005-3008
37. Sanchez V Vazquez JA Barth-Jones D Dembry L Sobel JD Zervos MJ Nosocomial acquisition of Candida parapsilosis: an epidemiologic study Am J Med 94 1993 577-582
38. Ghannoum MA Rice LB Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance Clin Microbiol Rev 12 1999 501-517